Stevenage. 05 November 2016. MBDA has been awarded a £100M Demonstration and Manufacture contract by the UK Ministry of Defence (MOD) for the Sea Ceptor air defence system for the UK Royal Navy’s (RN) new class of frigate, the Type 26 (T26) Global Combat Ship (GCS). This advanced missile system will provide the principal air defence of the T26 and nearby ships against advanced airborne threats including sea-skimming anti-ship missiles, fast jets, helicopters, and UAVS.
The contract is further evidence of the confidence placed in the capability and maturity of the Sea Ceptor system and its CAMM (Common Anti-air Modular Missile) munition by the UK MOD and the RN.
This Demonstration and Manufacture contract will run for 10 years and involves support to the T26 design as well as the manufacture of the electronics equipment required for the class of eight ships.
Welcoming the contract announcement, James Allibone MBDA’s UK Sales & Business Development Director said: “This investment in the Sea Ceptor system is going to give the Royal Navy and partner navies outstanding air defence cover. Thanks to the Portfolio Management Agreement with the UK MOD, MBDA is providing a common missile system for both naval and land use thereby significantly reducing the cost that would have been involved in developing separate systems”.
With Sea Ceptor now selected for five different naval platform types around the world, MBDA sees further potential for the system and the CAMM family of missiles with other navies. Dave Armstrong, MBDA Executive Group Director Sales & Business Development and UK Managing Director states: “Naval air defence is more critical than ever given the growing capability of airborne threats. CAMM’s operational flexibility and ease of integration, both as a retrofit or on a new build, combine to offer unrivalled product advantages. Customers appreciate that they are looking at a product which is at the very start of its lifecycle, a product that represents the very latest in air defence technology and one that will be supported with ongoing through life enhancements for at least the next thirty years or more”.